Back to FDA Applications sponsored by GLAXOSMITHKLINE CONS

FDA Drug Application 022122 by GLAXOSMITHKLINE CONS

Application Number022122
Application Type New Drug Application
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type New formulation
Therapeutic Potential Standard
Orphan Code 

Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP010/17/2007N18258000 10/22/2007
AP010/17/2007N18280000 10/22/2007
AP010/17/2007N19250000 2/22/2008
AP010/17/2007N19251000 2/22/2008
AP010/17/2007N28001000 3/1/2011
AP09/22/2009SLR23508006 10/1/2009
AP09/22/2009SLR23775006 11/10/2009
AP011/25/2014SLR41109007 11/28/2014
AP011/25/2014SLR41492007 1/5/2015
AP05/9/2016SLR45912010 5/11/2016
AP05/9/2016SLR45975010 5/11/2016

Back to FDA Applications sponsored by GLAXOSMITHKLINE CONS

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer

Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.